Literature DB >> 16001180

Comparison of modern marker proteins in serum and synovial fluid in patients with advanced osteoarthrosis and rheumatoid arthritis.

S Andereya1, N Streich, B Schmidt-Rohlfing, T Mumme, R Müller-Rath, U Schneider.   

Abstract

Numerous studies have focused on the significance of modern marker proteins in the synovial fluid of the knee joint and in the serum both, for osteoarthritis (OA) and rheumatoid arthritis (RA). The relationship between the serum concentrations and the concentrations in the synovial fluid is still unclear. Synovial fluid and serum samples were obtained from 13 patients with advanced OA and from 8 patients with severe RA and concentrations of MMP-1, MMP-3, MMP-13, TIMP-1, COMP and MIA/CD-RAP were determined. All values were normalized against the total protein concentrations. Serum concentrations of MMP-13 in the RA-group were statistically higher than the synovial values (P<0.05). MMP-13 was the only marker protein that revealed distinct higher levels in the serum than in the synovial fluid. The study design allows only conclusions about advanced stages of RA and OA. Longitudinal investigations may provide further information about the value of MMP-13 as a potential marker to monitor the course of RA and OA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16001180     DOI: 10.1007/s00296-005-0006-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  34 in total

1.  Increased levels of proteoglycan fragments in knee joint fluid after injury.

Authors:  L S Lohmander; L Dahlberg; L Ryd; D Heinegård
Journal:  Arthritis Rheum       Date:  1989-11

Review 2.  Matrix metalloproteinases and their clinical applications in orthopaedics.

Authors:  Diah S Bramono; John C Richmond; Paul P Weitzel; David L Kaplan; Gregory H Altman
Journal:  Clin Orthop Relat Res       Date:  2004-11       Impact factor: 4.176

3.  Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis.

Authors:  G Cunnane; O Fitzgerald; C Beeton; T E Cawston; B Bresnihan
Journal:  Arthritis Rheum       Date:  2001-10

Review 4.  Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?

Authors:  S Gay; R E Gay; W J Koopman
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

Review 5.  Activation mechanisms of matrix metalloproteinases.

Authors:  H Nagase
Journal:  Biol Chem       Date:  1997 Mar-Apr       Impact factor: 3.915

6.  Seropositivity for MIA and S100 in patients with gastrointestinal carcinomas.

Authors:  V Wagner; J Rudi; H Näher; W Stremmel
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.064

Review 7.  Expression, function and clinical relevance of MIA (melanoma inhibitory activity).

Authors:  A K Bosserhoff; R Buettner
Journal:  Histol Histopathol       Date:  2002-01       Impact factor: 2.303

8.  Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis.

Authors:  Y Yoshihara; K Obata; N Fujimoto; K Yamashita; T Hayakawa; M Shimmei
Journal:  Arthritis Rheum       Date:  1995-07

9.  Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.

Authors:  J Martel-Pelletier; R McCollum; N Fujimoto; K Obata; J M Cloutier; J P Pelletier
Journal:  Lab Invest       Date:  1994-06       Impact factor: 5.662

10.  Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.

Authors:  P G Mitchell; H A Magna; L M Reeves; L L Lopresti-Morrow; S A Yocum; P J Rosner; K F Geoghegan; J E Hambor
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

View more
  12 in total

1.  Parathyroid hormone activation of matrix metalloproteinase-13 transcription requires the histone acetyltransferase activity of p300 and PCAF and p300-dependent acetylation of PCAF.

Authors:  Minnkyong Lee; Nicola C Partridge
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

2.  Sirtuin 1 is a negative regulator of parathyroid hormone stimulation of matrix metalloproteinase 13 expression in osteoblastic cells: role of sirtuin 1 in the action of PTH on osteoblasts.

Authors:  Yurong Fei; Emi Shimizu; Michael W McBurney; Nicola C Partridge
Journal:  J Biol Chem       Date:  2015-01-28       Impact factor: 5.157

3.  Methodology and applications of disease biomarker identification in human serum.

Authors:  Ziad J Sahab; Suzan M Semaan; Qing-Xiang Amy Sang
Journal:  Biomark Insights       Date:  2007-02-14

4.  Relationship between Investigative Biomarkers and Radiographic Grading in Patients with Knee Osteoarthritis.

Authors:  Eduardo Anitua; Mikel Sánchez; Maria de la Fuente; Juan Azofra; Mar Zalduendo; Jose J Aguirre; Isabel Andía
Journal:  Int J Rheumatol       Date:  2009-04-06

5.  Interferon-gamma inhibits interleukin-1beta-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis.

Authors:  Charlotte E Page; Shaun Smale; Sara M Carty; Nicholas Amos; Sarah N Lauder; Rhian M Goodfellow; Peter J Richards; Simon A Jones; Nicholas Topley; Anwen S Williams
Journal:  Arthritis Res Ther       Date:  2010-03-22       Impact factor: 5.156

6.  Discoidin domain receptor 2 is associated with the increased expression of matrix metalloproteinase-13 in synovial fibroblasts of rheumatoid arthritis.

Authors:  Jin Su; Jiangtian Yu; Tingting Ren; Wei Zhang; Yuanqiang Zhang; Xinping Liu; Tiezheng Sun; Houshan Lu; Keiji Miyazawa; Libo Yao
Journal:  Mol Cell Biochem       Date:  2009-05-05       Impact factor: 3.396

7.  Measurement of MMP Activity in Synovial Fluid in Cases of Osteoarthritis and Acute Inflammatory Conditions of the Knee Joints Using a Fluorogenic Peptide Probe-Immobilized Diagnostic Kit.

Authors:  Ju Hee Ryu; Aeju Lee; Myung Sook Huh; Junuk Chu; Kwangmeyung Kim; Byung-Soo Kim; Kuiwon Choi; Ick Chan Kwon; Jong Woong Park; Inchan Youn
Journal:  Theranostics       Date:  2012-02-14       Impact factor: 11.556

8.  TGF-beta inhibits IL-1beta-activated PAR-2 expression through multiple pathways in human primary synovial cells.

Authors:  Shin-Han Tsai; Ming-Thau Sheu; Yu-Chih Liang; Hsiu-Tan Cheng; Sheng-Shiung Fang; Chien-Ho Chen
Journal:  J Biomed Sci       Date:  2009-10-23       Impact factor: 8.410

9.  Cartilage Oligomeric Matrix Protein Levels in Synovial Fluid in Patients With Primary Knee Osteoarthritis And Healthy Controls: A Preliminary Comparative Analysis With Serum Cartilage Oligomeric Matrix Protein.

Authors:  Ruben Daniel Arellano; Lizette Sarai Aguilar; Rafael Argüello; Fernando Hernadez; Faviel Francisco Gonzalez; Javier Moran
Journal:  Arch Rheumatol       Date:  2017-04-04       Impact factor: 1.472

10.  Synovial Fluid Biomarkers in Knee Osteoarthritis: A Systematic Review and Quantitative Evaluation Using BIPEDs Criteria.

Authors:  Angelo Boffa; Giulia Merli; Luca Andriolo; Christian Lattermann; Gian M Salzmann; Giuseppe Filardo
Journal:  Cartilage       Date:  2020-07-25       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.